Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular ...

For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...

Exotec®︎ a global warehouse robotics provider launches the next generation of Skypod®︎. Higher performance, improved storage ...

Exotec®︎, a global warehouse robotics provider, has launched the The Next Generation of Skypod®︎ system, offering higher performance, improved storage density, and advanced software features. Over the ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

CAMBRIDGE, MA AND PITTSBURGH, PA / ACCESSWIRE / 10, 2025 / Next Gen Diagnostics (NGD), a pioneer in the development of machine learning models for whol ...

TD Cowen downgraded Illumina (ILMN) to Hold from Buy with a price target of $140, down from $177. Accelerating high throughput next-generation ...

Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

Next-generation sequencing tests offer potential for more precise remission determination, but technical and financial barriers exist. Cost-effectiveness and payer acceptance are essential for ...

From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...